Developed strategic roadmaps for European biotech ventures to validate and commercialize novel drug candidates.
Collaborated within a Japanese, European, and US partnership to develop a new digital biomarker and commercial digital care solution for patients and HCPs addressing unmet medical needs.
Served as the Japan business representative for a European pharma company division, driving business development for novel medical devices and diagnostics software.
Cultivated relationships with local innovation ecosystems and startups to source new technologies for a global pharma company.
Facilitated local partnerships for Software as a Medical Device (SaMD) solutions commercialization.
Implemented custom digital solutions, including ePRO mobile applications for clinical studies.
Sourced blood biomarkers for point-of-care diagnostics device manufacturer.
Integrated IoT and wearable technologies into personalized healthcare solutions.
Automated data workflows for pharma business intelligence visualizations.
Explored blockchain applications and tangible benefits for pharma value chains.
Conducted workshops for international pharma teams on practical approaches to mapping and assessing digital transformation opportunities.
diabetes
cardiology
cancer
neurodegenerative
hemophilia
endometriosis